The advantages of the lipofilling procedure are offered by using a natural material, with which the patient’s body is compatible.

The transferred fat is composed from the patient’s own cells, so, the breast will have a very natural aspect. Plus, once the transfer is made, the result is permanent (after a 60% rate of absorption).

Adipose cells present on long term a lower risk comparing with breast implant. For example, the risk of further infections is lower than the one of the implants. Contracture risk is also lower.

The steps in breast lipofilling procedure

The procedure involves two steps. First step, adipose cells are being prelevated from different parts of the patient’s body where they are in excess or not necessary. For most women, these areas are: the abdomen, thighs and buttocks. Depending on the necessary augmented volume, between 500 – 1000 cm3 of adipose tissue will be prelevated. With the help of the system LipoKit ‘good’ fat cells will be separated from oils and other substances. With the help of this system, a bigger survival rate of the injected cells is ensured.

Using very smooth cannulas, viable cells are injected in the breast area so they will expand. After lipofilling, the breasts will look bigger than the final result, because of post-operatory tumefaction and of the fact that some adipose cells won’t survive the transfer. Usually, 60% of the transferred tissue survives, so breasts will decrease in volume for a period of 6 months after operation, when you will have the final result. In some cases, the cells survival rate is bigger, but in other the rate is lower. It is possible that small 5-10 mm scars remain in the areas where the fat tissue was prelevated (abdomen, thighs).

Possible side effects and risks

Any medical procedure involves risks, but the transfer of adipose tissue by lipofilling is relatively sure. Most common side effects are similar to liposuction (fat prelevating) and to adipose tissue injection procedure. One of the aspects that preoccupies most the patients is breast cancer. Tissue transfer with lipofilling does not increases the risk of breast cancer. In some cases the 40% of the cells that did not survived, can appear as small calcifications that are visible in specific investigations. In the past, these where mistaken with cancerous cells by radiologists who did the mammography. Today, with the help of modern mammography technology, calcifications caused by adipose tissue transfer are clearly distinguished form the cancerous cells.

There is no danger when breast feeding or pregnancy. Still, if the patient is pregnant or breast feeds, she will be advised by doctors to delay lipofilling procedure until breast feed or pregnancy ends.

Breast implants and lipofilling

The difference between the two procedures consists in the fact that lipofilling generates a relatively small size increasing. Depending on the breast size, between 100 – 300 cm3. Circa 40% of the cells won’t survive the transfer, so the final augmentation will be 60 – 180 cm3. With the help of mammary implants, breasts size can be increased up till 400 cm3 in one intervention. In a common language, lipofilling can increase breasts size with one number. Implants can generate a much bigger augmentation in only one intervention. Likewise, some patients who are minions and do not have enough adipose tissue for the lipofilling prelevation, will have to gain weight before the operation.